Biochemical Innovators for Healthier Futures
The Biomedical Research Foundation of the Academy of Athens brings together advancements in nanotechnology in the biomedical field. The Bionanotechnology and Nanochemistry Group has a strong expertise in the development of biosensors (with a special focus on the use of aptamers for sensing applications) and considerable experience in the characterization of biomolecular interactions for a range of different applications (drug delivery and screening, tissue engineering, biosensors).
![](https://static.wixstatic.com/media/caacd5_3af97f0a61e54b59bdeaca532e20aba8~mv2.png/v1/fill/w_800,h_800,al_c,q_90,enc_auto/BRFAA_logo.png)
Projects involved in
![Illustration of ViroGates’ multiplex microfluidic chip and its integration into the GENSPEED® xPOC platform.](https://static.wixstatic.com/media/b493e6_382057f7bcfb48cc967c4c8b5f39397f~mv2.png/v1/fill/w_980,h_733,al_c,q_90,usm_0.66_1.00_0.01,enc_auto/OEM-genspeed-biomarker-immobilization-microfluidic-chip-MIH.png)
Advancing Patient Triage with ViroGates' Multiplex Inflammatory Biomarker Detection
ViroGates, an international in vitro diagnostics company based in Denmark, is renowned for its innovative solutions in emergency medicine. Their suPARnostic® product line, used extensively in emergency departments, enhances clinical decisions regarding the hospitalization or discharge of acute medical patients.
![Illustration of EXIAS Medical’s microfluidic chip and its integration into the blood analysis device.](https://static.wixstatic.com/media/b493e6_caa83944d0ba45f3adf58f701c950a92~mv2.jpg/v1/fill/w_980,h_698,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/electrolyte-analyzer-exias.jpg)
Tackling Microfluidic Challenges with EXIAS Medical's Advanced Blood Analysis Device
EXIAS Medical, in partnership with the Microfluidics Innovation Hub, is advancing blood analysis with a microfluidic chip that measures critical blood parameters. This project tackles air bubble formation in microfluidic channels, enhancing sensor accuracy and ensuring reliable point-of-care diagnostics.
![Illustration of mepro sperm selection chip working principle.](https://static.wixstatic.com/media/b493e6_4f43484cd94c439fab361bda05286ce6~mv2.png/v1/fill/w_980,h_280,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/WORKING%20PRINCIPLE_no%20chip%20design%20sperm%20selection.png)
Revolutionizing IVF Success with MEPROlife's SpermSort Microfluidic Chip
MEPROlife's SpermSort technology revolutionizes sperm selection for assisted reproduction by combining advanced microfluidics with precise molecular diagnostics, significantly increasing pregnancy rates and improving IVF outcomes.
Contact us today and together we will evaluate which manufacturing process best suits your microfluidic needs!
Are you ready to scale-up?
Contact us to discuss your microfluidic project requirements and objectives.
Consultation
Partner Match
We connect you with the right manufacturing experts from our network.
We oversee the entire project, ensuring smooth coordination and timely delivery